{"log_id": 8945801626468899536, "direction": 0, "words_result_num": 32, "words_result": [{"probability": {"variance": 1e-05, "average": 0.997846, "min": 0.988958}, "location": {"width": 503, "top": 195, "height": 34, "left": 188}, "words": "不计。但局部用药可能发生轻至中度的结膜或巩膜充血"}, {"probability": {"variance": 3.4e-05, "average": 0.998218, "min": 0.963762}, "location": {"width": 786, "top": 238, "height": 38, "left": 229}, "words": "行囊外晶体摘除的猴子长期使用拉坦前列素,用荧光血管造影术确定不会影响视网膜血"}, {"probability": {"variance": 0, "average": 0.999975, "min": 0.999975}, "location": {"width": 26, "top": 299, "height": 24, "left": 186}, "words": "管"}, {"probability": {"variance": 9e-06, "average": 0.998597, "min": 0.985369}, "location": {"width": 506, "top": 339, "height": 34, "left": 228}, "words": "拉坦前列素短期治疗不会引起后房人工晶体荧光素渗漏"}, {"probability": {"variance": 2e-06, "average": 0.999058, "min": 0.995355}, "location": {"width": 672, "top": 383, "height": 38, "left": 229}, "words": "临床治疗剂量的拉坦前列素对心血管或呼吸系统未发现有明显的药理作用"}, {"probability": {"variance": 0.000114, "average": 0.993146, "min": 0.971924}, "location": {"width": 89, "top": 442, "height": 24, "left": 191}, "words": "毒理研究:"}, {"probability": {"variance": 7e-06, "average": 0.998692, "min": 0.983782}, "location": {"width": 787, "top": 477, "height": 37, "left": 230}, "words": "用数种动物进行了拉坦前列素的眼部和全身毒性作用研究。总的来说,拉坦前列素可很"}, {"probability": {"variance": 7.1e-05, "average": 0.997586, "min": 0.945195}, "location": {"width": 829, "top": 524, "height": 38, "left": 188}, "words": "好地耐受,安全范围很大,临床眼用剂量和全身毒性剂量至少相差1000倍。未经麻醉的猴"}, {"probability": {"variance": 0.001307, "average": 0.992361, "min": 0.765157}, "location": {"width": 817, "top": 571, "height": 38, "left": 190}, "words": "子静脉注射高剂量拉坦前列素(约为临床剂量/公斤体重的100倍),观察到呼吸频率增加"}, {"probability": {"variance": 6e-06, "average": 0.998766, "min": 0.986873}, "location": {"width": 713, "top": 619, "height": 37, "left": 190}, "words": "可能反映了短暂的支气管收缩。动物实验中未发现拉坦前列素有致敏性的特性"}, {"probability": {"variance": 0.023275, "average": 0.942933, "min": 0.391401}, "location": {"width": 785, "top": 665, "height": 36, "left": 233}, "words": "在家兔和猴子列素剂量达100ug眼天时也未观察到眼部毒性作用(临床剂量"}, {"probability": {"variance": 0.020114, "average": 0.930679, "min": 0.460502}, "location": {"width": 501, "top": 714, "height": 35, "left": 192}, "words": "为1.5μg//天但拉坦前列素引起猴子虹膜色素增加"}, {"probability": {"variance": 0.005497, "average": 0.984674, "min": 0.544015}, "location": {"width": 776, "top": 758, "height": 39, "left": 233}, "words": "色素增加的机制似乎是刺激了虹膜黑素细胞内黑色素的产生,但未观察到增殖性改变"}, {"probability": {"variance": 0.000356, "average": 0.991077, "min": 0.935264}, "location": {"width": 277, "top": 813, "height": 35, "left": 190}, "words": "虹膜色素改变可能性的"}, {"probability": {"variance": 0.000398, "average": 0.988824, "min": 0.948944}, "location": {"width": 106, "top": 862, "height": 26, "left": 233}, "words": "在长期眼毒"}, {"probability": {"variance": 0.006162, "average": 0.972951, "min": 0.62164}, "location": {"width": 580, "top": 851, "height": 38, "left": 440}, "words": "给予拉坦前列素6μg/眼/天还引起睑裂加大,该作用可逆并只在"}, {"probability": {"variance": 2.7e-05, "average": 0.997186, "min": 0.97636}, "location": {"width": 486, "top": 904, "height": 34, "left": 191}, "words": "剂量高于临床剂量时发生。这一作用在人类未观察到"}, {"probability": {"variance": 9e-06, "average": 0.998866, "min": 0.983592}, "location": {"width": 788, "top": 946, "height": 38, "left": 233}, "words": "拉坦前列素在细菌回复突变实验、小鼠淋巴瘤的基因突变实验和小鼠微核实验中均呈阴"}, {"probability": {"variance": 0.000362, "average": 0.994435, "min": 0.898854}, "location": {"width": 548, "top": 998, "height": 34, "left": 192}, "words": "性。体外人淋巴细胞实验中观察到染色体异常。前列腺素F2"}, {"probability": {"variance": 1e-06, "average": 0.99892, "min": 0.997116}, "location": {"width": 232, "top": 995, "height": 27, "left": 789}, "words": "种正常情况下存在的前列"}, {"probability": {"variance": 1e-06, "average": 0.999044, "min": 0.994546}, "location": {"width": 548, "top": 1044, "height": 36, "left": 192}, "words": "腺素,也观察到类似作用,表明该作用为这一类物质所共有"}, {"probability": {"variance": 2e-06, "average": 0.99912, "min": 0.9933}, "location": {"width": 788, "top": 1087, "height": 39, "left": 236}, "words": "关于致突变实验,进行了大鼠体内和体外的非程序性DNA合成研究,结果呈阴性,表"}, {"probability": {"variance": 3e-06, "average": 0.999298, "min": 0.991192}, "location": {"width": 567, "top": 1137, "height": 36, "left": 195}, "words": "明拉坦前列素无致突变作用。小鼠和大鼠的致癌实验也呈阴性"}, {"probability": {"variance": 0.000432, "average": 0.995751, "min": 0.869517}, "location": {"width": 786, "top": 1181, "height": 37, "left": 236}, "words": "动物实验中未发现拉坦前列素对雄性和雌性生育力有任何影响。在大鼠胚胎毒性研究中"}, {"probability": {"variance": 0.003383, "average": 0.987, "min": 0.632079}, "location": {"width": 829, "top": 1227, "height": 41, "left": 194}, "words": "拉坦前列素静脉给药剂量为5、50和250μg/kg/天未观察到任何胚胎毒性。但在家兔,拉坦"}, {"probability": {"variance": 0.000158, "average": 0.994297, "min": 0.948991}, "location": {"width": 432, "top": 1281, "height": 33, "left": 196}, "words": "前列素剂量5μg/kg天或以上时可引起胚胎死亡"}, {"probability": {"variance": 0.000468, "average": 0.994461, "min": 0.860688}, "location": {"width": 785, "top": 1321, "height": 40, "left": 238}, "words": "剂量5μg/kg天(约为临床剂量的100倍)可引起明显的胚胎胎儿毒性,表现为晚期吸"}, {"probability": {"variance": 2e-06, "average": 0.99908, "min": 0.993911}, "location": {"width": 360, "top": 1376, "height": 31, "left": 196}, "words": "收和流产发生率增加以及胎儿重量降低"}, {"probability": {"variance": 2e-06, "average": 0.99895, "min": 0.99551}, "location": {"width": 234, "top": 1424, "height": 29, "left": 239}, "words": "未发现任何潜在致畸作用"}, {"probability": {"variance": 2e-06, "average": 0.998877, "min": 0.996537}, "location": {"width": 139, "top": 1473, "height": 26, "left": 204}, "words": "【药代动力学】"}, {"probability": {"variance": 1.5e-05, "average": 0.997899, "min": 0.980081}, "location": {"width": 790, "top": 1509, "height": 40, "left": 239}, "words": "拉坦前列素(分子量432.58)为异丙酯化的前药,无活性。当水解转化为拉坦前列素酸"}, {"probability": {"variance": 7e-06, "average": 0.998568, "min": 0.983404}, "location": {"width": 832, "top": 1557, "height": 39, "left": 197}, "words": "以后具有生物活性。前药可通过角膜很好地吸收,进入房水的药物在透过角膜时已全部被水"}], "language": 3}